ClinicalTrials.Veeva

Menu

Optimal Sensing in Atrial Tachyarrhythmia's Study (OSAT)

Abbott logo

Abbott

Status

Terminated

Conditions

Paroxysmal Atrial Fibrillation
Sick Sinus Syndrome

Treatments

Device: Accent Pacemaker

Study type

Interventional

Funder types

Industry

Identifiers

NCT01074749
CR-09-058-ND-LV

Details and patient eligibility

About

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), and the rejection of far field sensing of the far field R-wave (FFRW).

Full description

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal AF and AT and the rejection of far field sensing of the far field R-wave (FFRW). The study aims to evaluate the accuracy of the detection of atrial tachyarrhythmias (ATAs). An improved detection can potentially increase the accuracy of clinical treatment decisions, based on device derived data.

Enrollment

111 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with class I or II pacing indications for Sick Sinus Syndrome with suspected paroxysmal atrial tachyarrhythmias over the last 6 months
  • Signed informed consent
  • Age >18 yrs

Exclusion criteria

  • Severe valvular heart disease (echocardiogram less than 6 months old)
  • Angina Pectoris class ≥ III
  • Congestive heart failure - NYHA class ≥ III
  • Left Ventricular Ejection Fraction < 35% (less than 6 months old)
  • Hypertrophic Cardiomyopathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

111 participants in 2 patient groups

Optisense lead
Active Comparator group
Description:
Patients with an Accent pacemaker and an OptiSense atrial lead
Treatment:
Device: Accent Pacemaker
Tendril lead
Active Comparator group
Description:
Patients with an Accent pacemaker and a Tendril atrial lead
Treatment:
Device: Accent Pacemaker

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems